Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder caused by mutations in several different genes coding for contractile proteins. It can occur sporadically or in an autosomal dominant pattern of inheritance. It may be first diagnosed during pregnancy and can remain well tolerated. Nevertheless, early diagnosis and referral is crucial to ensure comprehensive management and risk evaluation is being made in order to prevent complications such as arrhythmia, heart failure and sudden cardiac death
